Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.945 EUR | +0.85% | +2.94% | +4.48% |
17/04 | Sonae Unit Closes Purchase of Majority Stake in BCF Life Sciences-owner Diorren | MT |
19/03 | Sonae Issues EUR150 Million Bonds | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company shows low valuation levels, with an enterprise value at 0.4 times its sales.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Retail & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.48% | 1.93B | B+ | ||
-7.21% | 38.45B | A- | ||
+9.83% | 35.53B | C | ||
+9.36% | 33.86B | A | ||
+9.52% | 20.2B | B | ||
+0.99% | 14.29B | B | ||
-14.41% | 12.77B | B- | ||
+16.48% | 11.85B | B- | ||
-.--% | 11.82B | - | - | |
-3.56% | 11.75B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SON Stock
- Ratings Sonae - SGPS, SA